Gilles de la Tourette syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
177
|
63
|
0.300 |
None |
0.889 |
18 |
|
1990 |
2018 |
Hyperprolactinemia
|
disease |
Nervous System Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
48
|
10
|
0.600 |
None |
0.923 |
13 |
|
2004 |
2020 |
Dyskinetic syndrome
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
316
|
42
|
0.400 |
None |
1.000 |
13 |
|
1999 |
2018 |
Cocaine-Related Disorders
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
121
|
|
0.500 |
None |
1.000 |
11 |
|
2000 |
2010 |
Alcohol abuse
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
156
|
24
|
0.570 |
None |
1.000 |
11 |
|
1994 |
2015 |
Huntington Disease
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
978
|
115
|
0.090 |
None |
1.000 |
9 |
|
1996 |
2019 |
Depressive Symptoms
|
phenotype |
Behavior and Behavior Mechanisms
|
Sign or Symptom
|
421
|
120
|
0.090 |
None |
1.000 |
9 |
|
2007 |
2020 |
Substance Dependence
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
156
|
19
|
0.380 |
None |
1.000 |
9 |
|
1999 |
2015 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.090 |
None |
1.000 |
9 |
|
2000 |
2019 |
Bulimia
|
disease |
Pathological Conditions, Signs and Symptoms
|
Mental or Behavioral Dysfunction
|
76
|
30
|
0.070 |
None |
1.000 |
7 |
|
2008 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.070 |
None |
1.000 |
7 |
|
2000 |
2019 |
Marijuana Abuse
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
156
|
23
|
0.370 |
None |
0.500 |
7 |
|
2010 |
2018 |
Dystonia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
453
|
97
|
0.070 |
None |
1.000 |
7 |
|
1998 |
2019 |
Alcohol Use Disorder
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
218
|
54
|
0.070 |
None |
0.857 |
7 |
|
1996 |
2020 |
Dystonia Disorders
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
167
|
37
|
0.060 |
None |
1.000 |
6 |
|
1998 |
2019 |
Hyperaldosteronism
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
84
|
6
|
0.200 |
None |
1.000 |
6 |
|
1995 |
2002 |
Extrapyramidal Disorders
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
27
|
1
|
0.310 |
None |
1.000 |
6 |
|
2000 |
2009 |
Impaired cognition
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
1630
|
348
|
0.060 |
None |
1.000 |
6 |
|
2004 |
2018 |
Cushing Syndrome
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
126
|
9
|
0.200 |
None |
1.000 |
6 |
|
1995 |
2002 |
MAJOR AFFECTIVE DISORDER 2
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Mental Disorders
|
Mental or Behavioral Dysfunction
|
185
|
34
|
0.060 |
None |
0.833 |
6 |
|
1994 |
2002 |
Catalepsy
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Mental or Behavioral Dysfunction
|
43
|
|
0.310 |
None |
1.000 |
5 |
|
1988 |
2018 |
nervous system disorder
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
977
|
39
|
0.050 |
None |
1.000 |
5 |
|
2000 |
2013 |
Glioblastoma Multiforme
|
disease |
Neoplasms
|
Neoplastic Process
|
3197
|
186
|
0.050 |
None |
1.000 |
5 |
|
2014 |
2020 |
Extrapyramidal sign
|
phenotype |
|
Sign or Symptom
|
116
|
7
|
0.050 |
None |
1.000 |
5 |
|
2002 |
2018 |
Alcohol or Other Drugs use
|
disease |
|
Mental or Behavioral Dysfunction
|
108
|
21
|
0.050 |
None |
1.000 |
5 |
|
1994 |
2017 |